Led by Lara Danziger-Isakov, MD (CCHMC)

The study’s goal is to evaluate the variation in CMV prevention strategies and the effectiveness of the strategies among participating transplant centers.

Led by Chet Villa, MD, MPH (CCHMC)

The study’s goal is to identify the patient phenotype at risk for complications related to occult cardiovascular disease and determine if patients with cardiac disease have increased morbidity and mortality during the pre-transplant and peri-operative periods.